Audit 46553

FY End
2022-12-31
Total Expended
$95.52M
Findings
0
Programs
38
Organization: The Jackson Laboratory (ME)
Year: 2022 Accepted: 2023-06-20
Auditor: Kpmg LLP

Organization Exclusion Status:

Checking exclusion status...

Findings

No findings recorded

Programs

ALN Program Spent Major Findings
93.397 Cancer Centers Support Grants $2.20M Yes 0
93.395 Cancer Treatment Research $860,534 Yes 0
93.113 Environmental Health $827,519 Yes 0
93.286 Discovery and Applied Research for Technological Innovations to Improve Human Health $657,726 Yes 0
93.394 Cancer Detection and Diagnosis Research $552,316 Yes 0
93.310 Trans-Nih Research Support $531,531 Yes 0
93.393 Cancer Cause and Prevention Research $371,270 Yes 0
93.353 21st Century Cures Act - Beau Biden Cancer Moonshot $367,257 Yes 0
93.351 Research Infrastructure Programs $350,282 Yes 0
47.074 Biological Sciences $258,807 Yes 0
93.867 Vision Research $232,405 Yes 0
93.279 Drug Abuse and Addiction Research Programs $214,028 Yes 0
93.846 Arthritis, Musculoskeletal and Skin Diseases Research $194,666 Yes 0
93.847 Diabetes, Digestive, and Kidney Diseases Extramural Research $163,847 Yes 0
93.351 Research Infrastructure Programs - Covid 19 $136,280 Yes 0
93.398 Cancer Research Manpower $112,372 Yes 0
93.837 Cardiovascular Diseases Research $89,886 Yes 0
93.866 Aging Research - Covid 19 $81,958 Yes 0
93.859 Biomedical Research and Research Training $59,900 Yes 0
93.847 Diabetes, Digestive, and Kidney Diseases Extramural Research - Covid 19 $54,800 Yes 0
93.396 Cancer Biology Research $42,853 Yes 0
93.350 National Center for Advancing Translational Sciences $35,394 Yes 0
93.121 Oral Diseases and Disorders Research $34,545 Yes 0
93.173 Research Related to Deafness and Communication Disorders $34,250 Yes 0
93.865 Child Health and Human Development Extramural Research $29,712 Yes 0
12.420 Military Medical Research and Development $24,031 Yes 0
93.172 Human Genome Research $17,701 Yes 0
93.310 Trans-Nih Research Support - Covid 19 $17,113 Yes 0
47.076 Education and Human Resources $14,394 Yes 0
10.310 Agriculture and Food Research Initiative (afri) $14,150 Yes 0
93.866 Aging Research $11,722 Yes 0
93.242 Mental Health Research Grants $11,183 Yes 0
93.855 Allergy and Infectious Diseases Research $9,743 Yes 0
93.853 Extramural Research Programs in the Neurosciences and Neurological Disorders $9,144 Yes 0
93.855 Allergy and Infectious Diseases Research - Covid 19 $8,460 Yes 0
47.070 Computer and Information Science and Engineering $8,052 Yes 0
93.273 Alcohol Research Programs $5,306 Yes 0
93.233 National Center on Sleep Disorders Research $1,694 Yes 0

Contacts

Name Title Type
XR6LMXNKDJJ1 Gerard Langlais Auditee
2072886180 Jayme Silva Auditor
No contacts on file

Notes to SEFA

Accounting Policies: The accompanying schedule of expenditures of federal awards presents expenditures of all federal awards programs of The Jackson Laboratory (the Laboratory), including awards passed through to the Laboratory from other organizations (i.e., primary recipients), for the year ended December 31, 2022. The schedule is presented using the modified cash basis of accounting. Negative amounts (if any) on the schedule represent cash transfer adjustments to expenditures reported in a prior year. The Laboratory has not elected to utilize the 10% de minimus indirect cost rate in Part 200.514 of the Uniform Guidance.For purposes of the schedule, federal awards include grants, contracts, and similar agreements entered into directly between the Laboratory and agencies and departments of the federal government and all subawards to the Laboratory by nonfederal organizations pursuant to federal grants, contracts, and similar agreements. The awards are categorized in accordance with the provisions of Title 2 U.S. Code of Federal Regulations Part 200, Uniform Administrative Requirements, Cost Principles, and Audit Requirements for Federal Awards (Uniform Guidance). Because the schedule presents only a selected portion of the operations of the Laboratory, it is not intended to and does not present the financial position, changes in net assets or cash flows of the Laboratory. De Minimis Rate Used: N Rate Explanation: The auditee did not use the de minimis cost rate.